Currently, two vaccines - Covishield and covaxin - are being used in the ongoing vaccination campaign against Corona in India. A third vaccine may be added soon. This Russian vaccine is expected to be Sputnik V. Dr Reddy's Laboratory, a Hyderabad-based company in India, is conducting its trials and is expected to approach the drug regulator in March for emergency approval. This vaccine will be available in India for $ 10 (about Rs 730).
Of the 10 vaccines approved worldwide, Sputnik V as well as the vaccines of American companies Pfizer and Mordana have proved to be more than 90% effective. For this reason, the fight against Corona can be expected to be strengthened with the availability of the Russian vaccine in India. The Russian vaccine has been created by the Gamalaya Institute of Russia and funded by the Russian Direct Investment Fund (RDIF). RDIF is also doing the deal on this vaccine from around the world.
RDIF CEO Kirill Dmitriev said that the price of the Moderna and Pfizer vaccines, which currently prove more than 90% efficacy, is three times the price of Sputnik V. With this, the Russian vaccine is being tried to reach more and more countries all over the world. The good thing is that it can be stored at a temperature of 2 to 8 ° C which is readily available in the current supply chain. The Russian vaccine is composed of two adenovirus vectors. The company is currently in talks with British firm AstraZeneca on combined trials with its vaccine - CoveShield. The company claims that the effectiveness of the AstraZeneca vaccine will increase further.
India will have the most effective and affordable vaccine
If the Russian vaccine is successful in all trials and is approved in India, it will be the most effective vaccine in trials. The efficacy of the Covishield vaccine being used in India has been 70%, while the phase-3 trials of Covaxin have not been completed yet. Because of this, the situation regarding its effectiveness is not clear.
The government is getting one dose of Covshield for 200 rupees and one dose of Covaxin for 295 rupees. At the same time, CoviShield's dose in the market will be Rs 1,000. Covaxin has not yet disclosed the market price. In such a situation, Sputnik V priced at Rs 730 can be the cheapest and effective vaccine in the market.
Which countries have received approval so far
Dimitrev said Sputnik V has so far received approval in Russia, Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, UAE, Turkmenistan. Hungary has become the first country in the European Union to approve it. Approval can be obtained soon from the Drug Regulator of the European Union.
Crude oil from Russia is still reaching buyers around the world. But how this oil is reaching dif
Best Phone Offer: Amazon is offering a bumper discount on 2 latest launch phones worth 10 thousand!
Best Phone under 10000 On Amazon: OPPO A57 and realme narzo 50A are two newly launched phones, wh
The pace of the HMPV virus is increasing rapidly in the country. Now the second case of HMPV has
Instructions have been issued to arrest migrants from the Fahheel area who demonstrated after Fri
Maharashtra Chief Minister Uddhav Thackeray talks about the recent raids conducted by the Narcoti
Jharkhand, IT Raid: Income Tax raids on the locations of Congress MLAs Anoop Singh and Pradeep Yadav
Income Tax raids on MLA Anoop Singh and Pradeep Yadav The Income Tax Department has started simul
Kartik Aaryan and Kiara Advani starrer film 'Satyaprem Ki Katha', directed by Sameer Vidwans, hit
In Mangaluru, a police officer caught the thief in a filmy style. They ran after him to catch the
Afghanistan News: IS Khorasan wants to destroy the Taliban, China is also a reason behind this
Now two terrorist organizations are face to face in Afghanistan. The Taliban, which has captured
Corona cases have started increasing once again in the country. 3712 new infections have been fou
